Global NK Cells Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152976
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Pharmaceuticals and Healthcare

Scope of the Report:

This report focuses on the NK Cells in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for NK Cells is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Chipscreen Biosciences (China)

Affimed NV (Netherlands)

Altor BioScience Corporation (USA)

Innate Pharma SA (France)

Takeda Pharmaceutical (Japan)

Sorrento Therapeutics Inc. (USA)

NantKwest Inc. (USA)

Bristol-Myers Squibb (USA)

NKT Therapeutics (USA)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mogamulizumab

Lorvotuzumab Mertansine

Others

Market Segment by Applications, can be divided into

Cancer

Cardiovascular Diseases

Others

There are 15 Chapters to deeply display the global NK Cells market.

Chapter 1, to describe NK Cells Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of NK Cells, with sales, revenue, and price of NK Cells, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of NK Cells, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, NK Cells market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe NK Cells sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 NK Cells Introduction

1.2 Market Analysis by Type

1.2.1 Mogamulizumab

1.2.2 Lorvotuzumab Mertansine

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Cancer

1.3.2 Cardiovascular Diseases

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Chipscreen Biosciences (China)

2.1.1 Business Overview

2.1.2 NK Cells Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Chipscreen Biosciences (China) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Affimed NV (Netherlands)

2.2.1 Business Overview

2.2.2 NK Cells Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Affimed NV (Netherlands) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Altor BioScience Corporation (USA)

2.3.1 Business Overview

2.3.2 NK Cells Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Altor BioScience Corporation (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Innate Pharma SA (France)

2.4.1 Business Overview

2.4.2 NK Cells Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Innate Pharma SA (France) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Takeda Pharmaceutical (Japan)

2.5.1 Business Overview

2.5.2 NK Cells Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sorrento Therapeutics Inc. (USA)

2.6.1 Business Overview

2.6.2 NK Cells Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sorrento Therapeutics Inc. (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 NantKwest Inc. (USA)

2.7.1 Business Overview

2.7.2 NK Cells Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NantKwest Inc. (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Bristol-Myers Squibb (USA)

2.8.1 Business Overview

2.8.2 NK Cells Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Bristol-Myers Squibb (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 NKT Therapeutics (USA)

2.9.1 Business Overview

2.9.2 NK Cells Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 NKT Therapeutics (USA) NK Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global NK Cells Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global NK Cells Sales and Market Share by Manufacturer (2016-2017)

3.2 Global NK Cells Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 NK Cells Manufacturer Market Share in 2017

3.3.2 Top 6 NK Cells Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global NK Cells Market Analysis by Regions

4.1 Global NK Cells Sales, Revenue and Market Share by Regions

4.1.1 Global NK Cells Sales and Market Share by Regions (2013-2018)

4.1.2 Global NK Cells Revenue and Market Share by Regions (2013-2018)

4.2 North America NK Cells Sales and Growth Rate (2013-2018)

4.3 Europe NK Cells Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific NK Cells Sales and Growth Rate (2013-2018)

4.5 South America NK Cells Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa NK Cells Sales and Growth Rate (2013-2018)

5 North America NK Cells by Countries

5.1 North America NK Cells Sales, Revenue and Market Share by Countries

5.1.1 North America NK Cells Sales and Market Share by Countries (2013-2018)

5.1.2 North America NK Cells Revenue and Market Share by Countries (2013-2018)

5.2 United States NK Cells Sales and Growth Rate (2013-2018)

5.3 Canada NK Cells Sales and Growth Rate (2013-2018)

5.4 Mexico NK Cells Sales and Growth Rate (2013-2018)

6 Europe NK Cells by Countries

6.1 Europe NK Cells Sales, Revenue and Market Share by Countries

6.1.1 Europe NK Cells Sales and Market Share by Countries (2013-2018)

6.1.2 Europe NK Cells Revenue and Market Share by Countries (2013-2018)

6.2 Germany NK Cells Sales and Growth Rate (2013-2018)

6.3 UK NK Cells Sales and Growth Rate (2013-2018)

6.4 France NK Cells Sales and Growth Rate (2013-2018)

6.5 Russia NK Cells Sales and Growth Rate (2013-2018)

6.6 Italy NK Cells Sales and Growth Rate (2013-2018)

7 Asia-Pacific NK Cells by Countries

7.1 Asia-Pacific NK Cells Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific NK Cells Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific NK Cells Revenue and Market Share by Countries (2013-2018)

7.2 China NK Cells Sales and Growth Rate (2013-2018)

7.3 Japan NK Cells Sales and Growth Rate (2013-2018)

7.4 Korea NK Cells Sales and Growth Rate (2013-2018)

7.5 India NK Cells Sales and Growth Rate (2013-2018)

7.6 Southeast Asia NK Cells Sales and Growth Rate (2013-2018)

8 South America NK Cells by Countries

8.1 South America NK Cells Sales, Revenue and Market Share by Countries

8.1.1 South America NK Cells Sales and Market Share by Countries (2013-2018)

8.1.2 South America NK Cells Revenue and Market Share by Countries (2013-2018)

8.2 Brazil NK Cells Sales and Growth Rate (2013-2018)

8.3 Argentina NK Cells Sales and Growth Rate (2013-2018)

8.4 Colombia NK Cells Sales and Growth Rate (2013-2018)

9 Middle East and Africa NK Cells by Countries

9.1 Middle East and Africa NK Cells Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa NK Cells Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa NK Cells Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia NK Cells Sales and Growth Rate (2013-2018)

9.3 UAE NK Cells Sales and Growth Rate (2013-2018)

9.4 Egypt NK Cells Sales and Growth Rate (2013-2018)

9.5 Nigeria NK Cells Sales and Growth Rate (2013-2018)

9.6 South Africa NK Cells Sales and Growth Rate (2013-2018)

10 Global NK Cells Market Segment by Type

10.1 Global NK Cells Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global NK Cells Sales and Market Share by Type (2013-2018)

10.1.2 Global NK Cells Revenue and Market Share by Type (2013-2018)

10.2 Mogamulizumab Sales Growth and Price

10.2.1 Global Mogamulizumab Sales Growth (2013-2018)

10.2.2 Global Mogamulizumab Price (2013-2018)

10.3 Lorvotuzumab Mertansine Sales Growth and Price

10.3.1 Global Lorvotuzumab Mertansine Sales Growth (2013-2018)

10.3.2 Global Lorvotuzumab Mertansine Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global NK Cells Market Segment by Application

11.1 Global NK Cells Sales Market Share by Application (2013-2018)

11.2 Cancer Sales Growth (2013-2018)

11.3 Cardiovascular Diseases Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 NK Cells Market Forecast (2018-2023)

12.1 Global NK Cells Sales, Revenue and Growth Rate (2018-2023)

12.2 NK Cells Market Forecast by Regions (2018-2023)

12.2.1 North America NK Cells Market Forecast (2018-2023)

12.2.2 Europe NK Cells Market Forecast (2018-2023)

12.2.3 Asia-Pacific NK Cells Market Forecast (2018-2023)

12.2.4 South America NK Cells Market Forecast (2018-2023)

12.2.5 Middle East and Africa NK Cells Market Forecast (2018-2023)

12.3 NK Cells Market Forecast by Type (2018-2023)

12.3.1 Global NK Cells Sales Forecast by Type (2018-2023)

12.3.2 Global NK Cells Market Share Forecast by Type (2018-2023)

12.4 NK Cells Market Forecast by Application (2018-2023)

12.4.1 Global NK Cells Sales Forecast by Application (2018-2023)

12.4.2 Global NK Cells Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure NK Cells Picture

Table Product Specifications of NK Cells

Figure Global Sales Market Share of NK Cells by Types in 2017

Table NK Cells Types for Major M

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery